Table 2B.
Characteristics of patients in the BF and 1W cohort.
| Characteristic (n=28) | BF | 1W | P |
|---|---|---|---|
| Gender (male/female) | 23/5 | ||
| Age | 54.39 ± 10.10 | ||
| Pathogeny (HBV/other) | 27/1 | ||
| Liver cirrhosis (no/compensated/decompensated) | 6/15/7 | ||
| Differentiation (well/moderate/poor/ND) | 2/3/5/18 | ||
| BCLC stage (0/A/B) | 2/23/3 | ||
| WBC (109/L) | 5.64 ± 2.30 | 7.45 ± 2.58 | 0.008 |
| HGB (g/L) | 146.79 ± 16.67 | 133.46 ± 15.80 | 0.006 |
| PLT (109/L) | 137.71 ± 53.93 | 160 ± 56.33 | 0.177 |
| ALT (U/L) | 32.23 ± 23.52 | 166.46 ± 138.31 | 0.000 |
| AST (U/L) | 30.36 ± 17.49 | 81.29 ± 67.12 | 0.000 |
| TBiL (μmmol/L) | 15.75 ± 6.28 | 18.85 ± 12.95 | 0.653 |
| ALB (g/L) | 40.57 ± 4.41 | 35.46 ± 4.07 | 0.000 |
| PT (s) | 11.99 ± 0.94 | 13.01 ± 1.34 | 0.028 |
| PTA (%) | 90.80 ± 11.30 | 80.63 ± 12.52 | 0.026 |
| AFP (ng/mL) | 341.91 ± 1036.78 | 114.45 ± 241.05 | 0.427 |
| PIVKA-II (mAU/mL) | 189.20 ± 279.96 | 73.29 ± 64.94 | 0.343 |
Bold font indicates statistical significance of P values.